Followed 207 TimesTop FollowedNYSE:MDT Medtronic (MDT) Stock Price, News & Analysis $88.48 -1.38 (-1.53%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$88.20 -0.28 (-0.32%) As of 05:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Medtronic Stock (NYSE:MDT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medtronic alerts:Sign Up Key Stats Today's Range$88.21▼$89.5950-Day Range$86.05▼$94.5852-Week Range$75.96▼$96.25Volume7.06 million shsAverage Volume6.55 million shsMarket Capitalization$113.48 billionP/E Ratio26.89Dividend Yield3.16%Price Target$96.07Consensus RatingHold Company OverviewMedtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.Written by Jeffrey Neal JohnsonRead More… Remove Ads Medtronic Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreMDT MarketRank™: Medtronic scored higher than 87% of companies evaluated by MarketBeat, and ranked 131st out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingMedtronic has received a consensus rating of Hold. The company's average rating score is 2.44, and is based on 6 buy ratings, 8 hold ratings, and 1 sell rating.Amount of Analyst CoverageMedtronic has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Medtronic's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth6.78% Earnings GrowthEarnings for Medtronic are expected to grow by 6.78% in the coming year, from $5.46 to $5.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medtronic is 26.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.59.Price to Earnings Ratio vs. SectorThe P/E ratio of Medtronic is 26.89, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.43.Price to Earnings Growth RatioMedtronic has a PEG Ratio of 2.22. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMedtronic has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Medtronic's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.00% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently decreased by 4.89%, indicating that investor sentiment is improving. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldMedtronic pays a meaningful dividend of 3.15%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthMedtronic has been increasing its dividend for 48 years.Dividend CoverageThe dividend payout ratio of Medtronic is 85.11%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Medtronic will have a dividend payout ratio of 48.03% next year. This indicates that Medtronic will be able to sustain or increase its dividend.Read more about Medtronic's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.25 Percentage of Shares Shorted1.00% of the float of Medtronic has been sold short.Short Interest Ratio / Days to CoverMedtronic has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Medtronic has recently decreased by 4.89%, indicating that investor sentiment is improving. News and Social Media2.9 / 5News Sentiment1.25 News SentimentMedtronic has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 81 news articles for Medtronic this week, compared to 30 articles on an average week.Search InterestOnly 25 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 201 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Medtronic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,911,368.00 in company stock.Percentage Held by InsidersOnly 0.20% of the stock of Medtronic is held by insiders.Percentage Held by Institutions82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medtronic's insider trading history. Receive MDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter. Email Address MDT Stock News Headlines2 Value Stocks I'm Buying Right NowApril 1 at 6:30 AM | fool.comTop Stock Reports for Mastercard, Medtronic & HCA HealthcareApril 1 at 2:35 AM | uk.finance.yahoo.comTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)Stifel Nicolaus Sticks to Its Hold Rating for Medtronic (MDT)March 31 at 9:35 PM | markets.businessinsider.comTD Cowen Remains a Buy on Medtronic (MDT)March 31 at 9:35 PM | markets.businessinsider.comMedtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price DipMarch 31 at 9:35 PM | finance.yahoo.comWhy Medtronic Stock Marched Higher on MondayMarch 31 at 7:04 PM | fool.comMedtronic Evolut TAVR system show durable clinical outcomesMarch 31 at 3:29 AM | markets.businessinsider.comSee More Headlines MDT Stock Analysis - Frequently Asked Questions How have MDT shares performed this year? Medtronic's stock was trading at $79.88 at the beginning of the year. Since then, MDT shares have increased by 10.8% and is now trading at $88.4840. View the best growth stocks for 2025 here. How were Medtronic's earnings last quarter? Medtronic plc (NYSE:MDT) posted its earnings results on Tuesday, February, 18th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.03. The medical technology company earned $8.29 billion during the quarter, compared to analyst estimates of $8.33 billion. Medtronic had a trailing twelve-month return on equity of 14.07% and a net margin of 12.83%. Read the conference call transcript. Who are Medtronic's major shareholders? Medtronic's top institutional investors include Confluence Investment Management LLC (0.02%), Centre Asset Management LLC (0.01%), MassMutual Private Wealth & Trust FSB (0.01%) and Cullen Investment Group LTD. (0.01%). Insiders that own company stock include Geoffrey Martha, Sean Salmon, Gregory L Smith, Hoedt Rob Ten, Brett A Wall and Michael Marinaro. View institutional ownership trends. How do I buy shares of Medtronic? Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medtronic own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medtronic investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Meta Platforms (META), NVIDIA (NVDA), Chevron (CVX), Verizon Communications (VZ) and Broadcom (AVGO). Company Calendar Record date for 1/10 Dividend12/27/2024Ex-Dividend for 1/10 Dividend12/27/2024Dividend Payable1/10/2025Last Earnings2/18/2025Record date for 4/11 Dividend3/28/2025Ex-Dividend for 4/11 Dividend3/28/2025Today4/02/2025Dividend Payable4/11/2025Fiscal Year End4/30/2025Next Earnings (Estimated)5/21/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Electromedical equipment Sub-IndustryHealth Care Equipment Current SymbolNYSE:MDT CIK1613103 Webwww.medtronic.com Phone(531) 438-1700Fax763-514-4879Employees95,000Year Founded1949Price Target and Rating Average Stock Price Target$96.07 High Stock Price Target$109.00 Low Stock Price Target$83.00 Potential Upside/Downside+8.6%Consensus RatingHold Rating Score (0-4)2.44 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)$3.29 Trailing P/E Ratio26.89 Forward P/E Ratio16.21 P/E Growth2.22Net Income$3.68 billion Net Margins12.83% Pretax Margin15.73% Return on Equity14.07% Return on Assets7.70% Debt Debt-to-Equity Ratio0.48 Current Ratio1.90 Quick Ratio1.39 Sales & Book Value Annual Sales$33.20 billion Price / Sales3.42 Cash Flow$7.25 per share Price / Cash Flow12.21 Book Value$38.69 per share Price / Book2.29Miscellaneous Outstanding Shares1,282,543,000Free Float1,279,721,000Market Cap$113.48 billion OptionableOptionable Beta0.80 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NYSE:MDT) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medtronic plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medtronic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.